Device System, Image Processing, Radiological

Immersivetouch

Payments companies reported to CMS as associated with Immersivetouch. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$2,150associated payments (2023-2025)
19clinicians with associated payments
1company reporting

By year

2025 $2,150

Payments reported as associated with Immersivetouch, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $840
Surgery $347
Neurological Surgery $204
Oral and Maxillofacial Surgery $172
Otolaryngology $156
Plastic Surgery Within The Head and Neck $152

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Immersivetouch

These are the largest totals companies reported as associated with Immersivetouch. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Daniel Cuadrado Tacoma, WA Thoracic Surgery (Cardiothoracic Vascular Surgery) $334.46
John Green Charlotte, NC Surgery $173.73
Bradley Thomas Charlotte, NC Surgery $173.73
Meredith Costello Seattle, WA Neurological Surgery $173.51
Craig Pearl Houston, TX Oral and Maxillofacial Surgery $171.77
Thomas Templin II Tacoma, WA Thoracic Surgery (Cardiothoracic Vascular Surgery) $170.67
John Kuckelman Joint Base Lewis Mcchord, WA Thoracic Surgery (Cardiothoracic Vascular Surgery) $170.67
Scott Louis Bellingham, WA Thoracic Surgery (Cardiothoracic Vascular Surgery) $163.79
Chad Purnell Chicago, IL Plastic Surgery Within The Head and Neck $151.52
Matthew Pontell Nashville, TN Plastic and Reconstructive Surgery $142.24

Prescribed Immersivetouch?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.